Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
117
days
Type 2 diabetes prevention across the life course
Authors
Yiying Wang; Jennifer L. Sargent; Chantal Mathieu; Elsa Vazquez-Arreola; Leigh Perreault; Ruth J. F. Loos; Lee-Ling Lim; Leontine Sandforth; Robert L. Hanson; Stephanie Kullmann; Julia Sbierski-Kind; Sara Y. Brucker; Martin Hrabé de Angelis; Fabian Theiss; Andrea Icks; Damon Mohebbi; Norbert Stefan; Viswanathan Mohan; Tiange Wang; Hubert Preissl; Michael Bergman; Jaakko Tuomilehto; Marie-France Hivert; Paul W. Franks; Andreas L. BirkenfeldShow moreShow less
Affiliations
1. Department of Internal Medicine IV—Diabetology, Endocrinology, Nephrology, University Hospital Tübingen, University of Tübingen, Tübingen, Germany; 2. Institute for Diabetes Research and Metabolic Diseases, Helmholtz Munich, Tübingen, Germany; 3. German Center for Diabetes Research, Neuherberg, Germany; 4. School of Public Health, Imperial College London, London, UK; 5. Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany; 6. Department of Endocrinology, UZ Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium; 7. National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, USA; 8. Division of Endocrinology, Metabolism and Diabetes, University of Colorado School of Medicine, Aurora, USA; 9. Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; 10. The Charles Bronfman Institute for Personalized Medicine, Department of AI in Health, Icahn School of Medicine at Mount Sinai, New York, USA; 11. Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia; 12. The M3 Research Center, University Hospital Tübingen, University of Tübingen, Tübingen, Germany; 13. Department of Women’s Health, University Hospital Tübingen, University of Tübingen, Tübingen, Germany; 14. Institute of Experimental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany; 15. Chair of Experimental Genetics, TUM School of Life Sciences, Technische Universität München, Freising, Germany; 16. Helmholtz Munich, Munich, Germany; 17. Institute for Health Services Research and Health Economics, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University Düsseldorf, Düsseldorf, Germany; 18. Institute for Health Services Research and Health Economics, Centre for Health and Society, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany; 19. Institute of General Practice, Centre for Health and Society, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany; 20. Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK; 21. Madras Diabetes Research Foundation (Indian Council of Medical Research Collaborating Centre of Excellence)–Dr. Mohan’s Diabetes Specialties Centre (International Diabetes Federation Centre of Excellence in Diabetes Care), Chennai, India; 22. National Clinical Research Center for Endocrine and Metabolic Diseases (Shanghai), Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 23. NYU Grossman School of Medicine, Department of Medicine, Holman Division of Endocrinology, Diabetes and Metabolism, New York, USA; 24. Department of Public Health, University of Helsinki, Helsinki, Finland; 25. Department of Population Medicine at Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, USA; 26. Diabetes Unit, Massachusetts General Hospital, Boston, USA; 27. Genetic & Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Lund University, Helsingborg, Sweden; 28. Precision Healthcare University Research Institute, Queen Mary University of London, London, UK; 29. Diabetes and Obesity Theme, School of Cardiovascular and Metabolic Medicine and Sciences, Faculty of Life Sciences and Medicine, King’s College London, London, UKShow moreShow less
388
days
Divergent impacts of explainable AI for dermatological diagnosis on clinicians versus lay people
Authors
Xuhai ‘Orson’ Xu; Haoyu Hu; Haoran Zhang; Will Ke Wang; Reina Wang; Luis R. Soenksen; Omar Badri; Sheharbano Jafry; Elise Burger; Lotanna Nwandu; Apoorva Mehta; Erik P. Duhaime; Asif Qasim; Hause Lin; Janis Karleen Pereira; Jonathan Hershon; Paulius Mui; Alejandro A. Gru; Noémie Elhadad; Lena Mamykina; Matthew Groh; Philipp Tschandl; Roxana Daneshjou; Marzyeh GhassemiShow moreShow less
Affiliations
1. Columbia University, New York, USA; 2. Cornell University, Ithaca, USA; 3. Massachusetts Institute of Technology, Cambridge, USA; 4. Johns Hopkins University, Baltimore, USA; 5. Northeast Dermatology Associates, Beverly, USA; 6. Stanford University, Stanford, USA; 7. University of Utah, Salt Lake City, USA; 8. OSF HealthCare, Peoria, USA; 9. Centaur.AI, Boston, USA; 10. MedShr, London, UK; 11. Pathway, Montréal, Canada; 12. X=Primary Care, Cambridge, USA; 13. Northwestern University, Evanston, USA; 14. Medical University of Vienna, Vienna, AustriaShow moreShow less
103
days
The next generation of antibody–drug conjugates
Authors
F. Mosele; A. Peltier; Y. Ozaki; A. Detappe; J. C. Soria; F. AndréShow moreShow less
Affiliations
1. Drug Development Department (DITEP), Gustave Roussy, Villejuif, France; 2. IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France; 3. INSERM U981, Gustave Roussy, Paris, France; 4. Department of Breast Medical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan; 5. Université Paris-Saclay, Gustave Roussy, Inserm U1363, Biothérapies Innovantes, Villejuif, France; 6. Institut Strauss, Strasbourg, France; 7. Equipe Labellisée Ligue Contre le Cancer, Paris, France; 8. Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, France; 9. Université Paris-Saclay, Gif-Sur-Yvette, France; 10. Amgen, R&D, Global Oncology Development, Thousand Oaks, USA; 11. Department of Medical Oncology, Gustave Roussy, Villejuif, FranceShow moreShow less
252
days
The genetic architecture of fibromyalgia across 2.5 million individuals
Authors
Isabel Kerrebijn; Gyda Bjornsdottir; Keon Arbabi; Lea Urpa; Hele Haapaniemi; Gudmar Thorleifsson; Lilja Stefansdottir; Stephan Frangakis; Jesse Valliere; Lovemore Kunorozva; Erik Abner; Caleb Ji; Markus Kangur; Bitten Aagaard; Henning Bliddal; Søren Brunak; Mie T. Bruun; Maria Didriksen; Christian Erikstrup; Sarah Finer; Arni J. Geirsson; Daniel F. Gudbjartsson; Thomas F. Hansen; David van Heel; Ingileif Jonsdottir; Stacey Knight; Kirk U. Knowlton; Christina Mikkelsen; Lincoln D. Nadauld; Thorunn A. Olafsdottir; Sisse R. Ostrowski; Ole B. V. Pedersen; Saedis Saevarsdottir; Astros T. Skuladottir; Erik Sørensen; Hreinn Stefansson; Patrick Sulem; Olafur A. Sveinsson; Gudny E. Thorlacius; Unnur Thorsteinsdottir; Henrik Ullum; Arnor Vikingsson; Thomas M. Werge; Richa Saxena; Kari Stefansson; Chad M. Brummett; Bente Glintborg; Daniel J. Clauw; Thorgeir E. Thorgeirsson; Frances M. K. Williams; Nasa Sinnott-Armstrong; Hanna M. Ollila; Michael WainbergShow moreShow less
Affiliations
1. Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada; 2. Institute of Medical Science, University of Toronto, Toronto, Canada; 3. Amgen deCODE Genetics, Reykjavik, Iceland; 4. Krembil Centre for Neuroinformatics, Centre for Addiction and Mental Health, Toronto, Canada; 5. Stanley Center for Psychiatric Research, Broad Institute, Cambridge, USA; 6. Center for Genomic Medicine, Massachusetts General Hospital, Boston, USA; 7. Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland; 8. Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, USA; 9. Molecular and Population Genetics Program, Broad Institute, Cambridge, USA; 10. Division of Sleep and Circadian Disorders, Brigham and Women’s Hospital, Boston, USA; 11. Institute of Genomics, Estonian Genome Center, University of Tartu, Tartu, Estonia; 12. Department of Computer Science, University of Toronto, Toronto, Canada; 13. Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark; 14. The Parker Institute, Copenhagen University Hospital Bispebjerg Frederiksberg, Copenhagen, Denmark; 15. Department of Public Health, University of Copenhagen, Copenhagen, Denmark; 16. Novo Nordisk Center for Protein Research, University of Copenhagen, Copenhagen, Denmark; 17. Clinical Immunology Research Unit, Department of Clinical Immunology, Odense University Hospital, Odense, Denmark; 18. Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; 19. Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark; 20. Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; 21. Wolfson Institute of Population Health, Queen Mary University of London, London, UK; 22. Department of Rheumatology, Landspitali University Hospital, Reykjavik, Iceland; 23. Neurogenomics, Translational Research Centre, Copenhagen University Hospital, Glostrup, Denmark; 24. Danish Multiple Sclerosis Center, Copenhagen University Hospital, Glostrup, Denmark; 25. Danish Headache Center, Copenhagen University Hospital, Glostrup, Denmark; 26. Blizard Institute, Queen Mary University of London, London, UK; 27. Precision Healthcare University Research Institute, Queen Mary University of London, London, UK; 28. Intermountain Medical Center, Intermountain Heart Institute, Salt Lake City, USA; 29. Intermountain Healthcare, Saint George, USA; 30. School of Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland; 31. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; 32. Department of Clinical Immunology, Zealand University Hospital, Koege, Denmark; 33. Department of Neurology, Landspitali University Hospital, Reykjavik, Iceland; 34. Statens Serum Institut, Copenhagen, Denmark; 35. Institute of Biological Psychiatry, Mental Health Services, Copenhagen University Hospital, Copenhagen, Denmark; 36. Department of Anesthesiology, Mass General Brigham, Harvard Medical School, Boston, USA; 37. Opioid Research Institute, Office for the Vice President for Research, University of Michigan, Ann Arbor, USA; 38. Overdose Prevention Engagement Network, Institute for Healthcare Policy and Innovation, Michigan Medicine, Ann Arbor, USA; 39. Copenhagen Center for Arthritis Research (COPECARE) and DANBIO, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark; 40. Chronic Pain and Fatigue Research Center, Department of Anesthesiology, University of Michigan, Ann Arbor, USA; 41. Department of Twin Research and Genetic Epidemiology, School of Life Course Sciences, King’s College London, London, UK; 42. Herbold Computational Biology Program, Fred Hutchinson Cancer Center, Seattle, USA; 43. Department of Genome Sciences, University of Washington, Seattle, USA; 44. Brotman Baty Institute, University of Washington, Seattle, USA; 45. Center for Synthetic Biology, University of Washington, Seattle, USA; 46. Center for One Health Research, University of Washington, Seattle, USA; 47. Department of Psychiatry, University of Toronto, Toronto, Canada; 48. Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, CanadaShow moreShow less
257
days
Integrated care pathway in individuals with Long COVID: STIMULATE-ICP, a cluster-randomized, phase 3 trial
Authors
STIMULATE-ICP ConsortiumShow moreShow less
Affiliations
1. University College London, London, UK; 2. Lancashire Clinical Trials Unit, University of Lancashire, Preston, UK; 3. The Francis Crick Institute, London, UK; 4. University College London Hospitals NHS Trust, London, UK; 5. Tameside and Glossop Integrated Care NHS Foundation Trust, Tameside General Hospital, Lancashire, UK; 6. Royal Free NHS Foundation Trust, London, UK; 7. Sheffield Teaching Hospitals NHS Foundation Trust, Northern General Hospital, Sheffield, UK; 8. Perspectum Ltd, Oxford, UK; 9. Applied Health Research Hub, University of Lancashire, Preston, UK; 10. Patient and Public Representative, C/O Institute of Health Informatics, University College London, London, UK; 11. Hull University Teaching Hospitals NHS Foundation Trust, Hull Royal Infirmary, Hull, UK; 12. Derbyshire Community Health Services NHS Foundation Trust, Ash Green Learning Disability Centre, Chesterfield, UK; 13. Living With Ltd, Brighton, UK; 14. Department of Health Sciences, University of York, York, UK; 15. University of Liverpool, Liverpool, UK; 16. University of Exeter, Exeter, UK; 17. Reading Central Primary Care Network, Pembroke Surgery, Reading, UK; 18. University of Southampton, Southampton, UK; 19. University Hospitals Sussex NHS Foundation Trust, Worthing Hospital, Worthing, UK; 20. Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK; 21. NHS England, London, UK; 22. Livewell Southwest, Plymouth, UK; 23. Department for Work and Pensions, London, UK; 24. Barts Health NHS Trust, The Royal London Hospital, London, UK; 25. NHS Highlands, Inverness, UK; 26. University of Leicester, Leicester, UK; 27. The Princess Alexandra Hospital NHS Trust, Harlow, UK; 28. University Hospitals of Leicester NHS Trust, Leicester Royal Infirmary, Leicester, UK; 29. University of Sussex, Brighton, UK; 30. University of Hull, Kingston upon Hull, UK; 31. Long Covid SOS, Aldridge, UK; 32. Department of Economics, The University of Auckland, Auckland, New Zealand; 33. Vauxhall Primary Care, Liverpool, UK; 34. Royal Devon and Exeter NHS Foundation Trust, Royal Devon and Exeter Hospital (Wonford), Exeter, UKShow moreShow less
306
days
Maternal 6-valent group B Streptococcus vaccine in non-pregnant and pregnant females: a randomized phase 1/2 trial
Authors
Shabir A. Madhi; Hasra Snaggs; Zahra Skogeby; Ye Feng; Shaun Barnabas; Jeffrey Baker; Lee Fairlie; Johannes Beeslaar; David Radley; Han-Qing Jiang; Natalie C. Silmon de Monerri; Raphael Simon; Lindsay McLaughlin; Michelle Gaylord; Julie Skinner; Iona Munjal; Annaliesa S. Anderson; Alejandra GurtmanShow moreShow less
Affiliations
1. South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; 2. Wits Infectious Diseases and Oncology Research Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; 3. Pfizer Vaccines, Pfizer Inc., Pearl River, USA; 4. Pfizer Vaccines, Pfizer Ltd, Marlow, UK; 5. Family Center for Research with Ubuntu, Department of Paediatrics and Child Health, Stellenbosch University, Stellenbosch, South Africa; 6. Clinical Research Prime, Idaho Falls, USA; 7. Wits RHI, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa; 8. Pfizer Vaccines, Pfizer Inc., Collegeville, USAShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days